Funding Opportunity Number: RFA-DK-27-139
Issuing agency: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
Application deadline: November 9, 2026 at 5:00 PM local time of the applicant organization under NIH submission policy, unless the controlling NOFO states otherwise.
Funding: The current federal listing reports $1,800,000 in total program funding for 1 expected award. Award minimum and maximum are not stated in the federal synopsis. Cost sharing is not required.
Purpose: This single-source U01 supports a three-year continuation of the COPE-AKI Scientific and Data Research Center so the existing consortium can meet enrollment targets, complete participant follow-up, and finalize data analysis and dissemination from the clinical trial studying care after Stage 2 and 3 acute kidney injury.
Eligibility: This is not an open competition. Only the current recipient under RFA-DK-20-012 is eligible to apply. Non-U.S. organizations and non-U.S. components of U.S. organizations are not eligible, and foreign components are not allowed under the posted notice.
Submission controls: Grants.gov lists the current full-announcement file RFA-DK-27-139-Full-Announcement.html, Version 1, posted August 31, 2026. The current recipient must follow the controlling Grants.gov package and full announcement for forms, attachments, budgets, clinical-trial materials, page limits, and all renewal requirements.
Atlas assessment: Restricted single-source continuation. Do not route for broad applicant outreach and do not treat structural applicant categories as expanding eligibility beyond the incumbent recipient specified by NIDDK.
Atlas score: 90/100 for program relevance; restricted routing.